• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌(HCC)中的“神经内分泌”分化:免疫组化反应性与不同的肿瘤细胞类型有关,但与肿瘤分级无关。

"Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.

作者信息

Zhao M, Laissue J A, Zimmermann A

机构信息

Institute of Pathology of the University, Bern, Switzerland.

出版信息

Histol Histopathol. 1993 Oct;8(4):617-26.

PMID:8305816
Abstract

We have analyzed neuroendocrine differentiation (ND) in hepatocellular carcinomas (HCCs) of fifty patients. It turned out that ND is frequent in HCCs, and that it is not restricted to fibrolamellar hepatocellular carcinoma (FL-HCC). Multiexpression is seen in a quarter of the cases, and marker coexpression may occur within the same tumor cell. ND predominates in trabecular and mixed HCCs, but does not appear to be related to grade. Most positive cases showed a hepatocyte-like cell morphology, frequently associated with bile formation. It thus appears that the HCC cell type most likely to show ND is a hepatocyte-like one, i.e. differentiated cell, frequently polarized and producing bile, rather than a small and poorly-differentiated cell. Possible pathogenic mechanisms leading to ND in HCCs are briefly discussed.

摘要

我们分析了50例肝细胞癌(HCC)中的神经内分泌分化(ND)情况。结果表明,ND在HCC中很常见,且不限于纤维板层肝细胞癌(FL - HCC)。四分之一的病例出现多表达,且标记物共表达可能发生在同一肿瘤细胞内。ND在小梁状和混合型HCC中占主导,但似乎与分级无关。大多数阳性病例呈现肝细胞样细胞形态,常与胆汁形成有关。因此,最有可能表现出ND的HCC细胞类型似乎是肝细胞样细胞,即分化细胞,常呈极化状态并产生胆汁,而非小的低分化细胞。文中简要讨论了HCC中导致ND的可能致病机制。

相似文献

1
"Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.肝细胞癌(HCC)中的“神经内分泌”分化:免疫组化反应性与不同的肿瘤细胞类型有关,但与肿瘤分级无关。
Histol Histopathol. 1993 Oct;8(4):617-26.
2
Apoptosis in hepatocellular carcinomas with neuroendocrine differentiation.
Histol Histopathol. 1997 Oct;12(4):973-80.
3
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.根据肝细胞和胆管分化标志物对肝细胞癌进行分类。临床及生物学意义。
Am J Pathol. 1996 Oct;149(4):1167-75.
4
Primary liver carcinoma arising in people younger than 30 years.30岁以下人群发生的原发性肝癌。
Am J Clin Pathol. 2005 Oct;124(4):512-8. doi: 10.1309/TT0R7KAL32228E99.
5
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.肝细胞癌、纤维板层样变体、肝硬化和正常肝脏中的肝细胞生长因子、间质-上皮转化因子及基质相关蛋白酶
Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB.
6
Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.具有胆管分化的小肝细胞癌的组织学特征及预后意义:细分及与普通肝细胞癌的比较
Am J Surg Pathol. 2007 May;31(5):783-91. doi: 10.1097/01.pas.0000213421.53750.0a.
7
Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.抗肝细胞克隆OCH1E5(Hep Par 1)在肝肿瘤组织学评估中的应用。
Indian J Pathol Microbiol. 2006 Jul;49(3):341-4.
8
The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.细胞角蛋白和癌胚抗原免疫染色在鉴别肝细胞癌与肝内胆管癌中的诊断价值。
J Gastrointestin Liver Dis. 2006 Mar;15(1):9-14.
9
The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.用于鉴别肝细胞癌与转移性腺癌的最佳免疫组织化学组合。
Pathol Res Pract. 2010 Aug 15;206(8):572-7. doi: 10.1016/j.prp.2010.03.004. Epub 2010 Apr 18.
10
Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Mod Pathol. 1996 Feb;9(2):99-104.

引用本文的文献

1
Liver collision tumor of primary hepatocellular carcinoma and neuroendocrine carcinoma: A rare case report.原发性肝细胞癌与神经内分泌癌的肝脏碰撞瘤:1例罕见病例报告
World J Clin Cases. 2022 Dec 16;10(35):13129-13137. doi: 10.12998/wjcc.v10.i35.13129.
2
Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.重新认识肝脏原发性上皮性肿瘤的细胞起源
J Hepatocell Carcinoma. 2021 Dec 7;8:1537-1563. doi: 10.2147/JHC.S334935. eCollection 2021.
3
Pleomorphic neoplasm in a liver: A potential pitfall for misdiagnosis.
肝脏中的多形性肿瘤:误诊的一个潜在陷阱。
Cytojournal. 2020 Apr 22;17:8. doi: 10.25259/Cytojournal_81_2019. eCollection 2020.
4
Incidental Collision Tumor of Hepatocellular Carcinoma and Neuroendocrine Carcinoma.肝细胞癌与神经内分泌癌的偶然碰撞瘤
J Clin Transl Hepatol. 2018 Sep 28;6(3):339-344. doi: 10.14218/JCTH.2017.00076. Epub 2018 Jun 28.
5
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.肝细胞癌与高级别神经内分泌癌:一例报告及文献综述
World J Oncol. 2011 Feb;2(1):37-40. doi: 10.4021/wjon276e. Epub 2011 Feb 26.
6
Undifferentiated carcinoma of the liver: a case report with immunohistochemical analysis.肝未分化癌:一例免疫组化分析病例报告
Surg Case Rep. 2017 Dec;3(1):12. doi: 10.1186/s40792-017-0288-0. Epub 2017 Jan 10.
7
Fibrolamellar carcinoma: 2012 update.纤维板层癌:2012年更新
Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Epub 2012 Sep 23.
8
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.肝细胞癌患者血清嗜铬粒蛋白A水平升高。
BMC Surg. 2012;12 Suppl 1(Suppl 1):S7. doi: 10.1186/1471-2482-12-S1-S7. Epub 2012 Nov 15.
9
Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.人食管鳞状细胞癌中的嗜铬粒蛋白A阳性肿瘤细胞。
Pathol Oncol Res. 2007;13(4):321-5. doi: 10.1007/BF02940311. Epub 2007 Dec 25.
10
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.肝脏肿瘤(肝细胞癌和高级别神经内分泌癌):一例病例报告及文献综述
Virchows Arch. 2006 Sep;449(3):376-81. doi: 10.1007/s00428-006-0251-0. Epub 2006 Aug 1.